These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21472266)

  • 1. Synergistic anti-neoplastic effect of AG1478 in combination with cisplatin or paclitaxel on human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Mol Med Rep; 2010; 3(3):479-84. PubMed ID: 21472266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2010 Jan; 25(1):97-103. PubMed ID: 19956907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Gynecol Oncol; 2008 Apr; 109(1):107-14. PubMed ID: 18234298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nasu K; Narahara H
    Gynecol Oncol; 2008 Nov; 111(2):336-43. PubMed ID: 18790523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T; Takai N; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
    Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Oncol Rep; 2008 Mar; 19(3):749-53. PubMed ID: 18288411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Anticancer Res; 2006; 26(2A):939-45. PubMed ID: 16619490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neoplastic effect of β-hydroxyisovalerylshikonin on a human choriocarcinoma cell line.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Mol Med Rep; 2010; 3(3):515-8. PubMed ID: 21472272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis.
    Zhou Y; Brattain MG
    Cancer Res; 2005 Jul; 65(13):5848-56. PubMed ID: 15994962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
    Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
    Takai N; Narahara H
    Curr Med Chem; 2007; 14(24):2548-53. PubMed ID: 17979707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
    Takai N; Ueda T; Kawano Y; Nishida M; Nasu K; Narahara H
    Oncol Rep; 2005 Nov; 14(5):1287-91. PubMed ID: 16211298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents.
    Coley HM; Shotton CF; Ajose-Adeogun A; Modjtahedi H; Thomas H
    Biochem Pharmacol; 2006 Oct; 72(8):941-8. PubMed ID: 16934227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.